GC012F Injection

· Daishi Tian

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GC012F Injection, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103) [EARLY_Phase 1]